Mergers & Acquisitions Mergers & Acquisitions

Illumina lodges appeal against EU regulator's Grail deal interim measures

Illumina lodged an appeal at the EU courts on Wednesday contesting the European Commission’s imposition of interim measures related to its Grail acquisition, MLex has learned.
The US gene-sequencing company is challenging the EU merger regulator's measures of Oct. 29, which it imposed following Illumina's decision to forge ahead with its

To view the latest version of this document and thousands of others like it, sign-in to MLex or register for a free trial.

Natalie McNelis

Senior Correspondent

Natalie McNelis covers mergers for MLex in Brussels. Before joining MLex in 2017, she spent 20 years as an international trade and competition lawyer in law firms including Stibbe and WilmerHale. Natalie has a BA in English from Mount Holyoke College, a JD from Harvard Law School and an LLM in EU law from KU Leuven. She is admitted to the bar in New York.

Discover MLex

Stay on top of global regulatory developments

Latest News